Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $835K | $335K | $153K | $7.91M | $12.6M | $5.17M | $6.07M | $7.30M | $7.81M | — |
| Revenue growth | — | -59.9% | -54.3% | 5069.9% | 59.7% | -59.1% | 17.5% | 20.2% | 7.0% | — |
| Operating income | -$24.9M | -$17.5M | -$20.4M | -$20.7M | -$9.86M | -$20.2M | -$18.9M | -$14.7M | -$9.76M | -$5.17M |
| Operating margin | -2978.0% | -5216.4% | -13333.3% | -261.6% | -78.1% | -390.2% | -312.1% | -202.0% | -125.1% | — |
| Net income | -$27.8M | -$18.1M | -$20.6M | -$20.6M | -$19.3M | -$20.2M | -$18.8M | -$14.1M | -$9.56M | -$5.16M |
| Net margin | -3334.5% | -5389.9% | -13439.9% | -260.4% | -152.8% | -390.2% | -310.3% | -193.5% | -122.5% | — |
| EPS (diluted) | -$1.88 | -$9.32 | -$4.98 | -$1.23 | -$13.43 | -$8.63 | -$5.46 | -$3.87 | -$2.62 | -$1.41 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13.2M | -$14.5M | -$16.8M | $3.23M | -$12.5M | -$19.7M | -$19.4M | -$16.0M | -$10.7M | -$5.43M |
| Capital expenditures | $455K | $74.0K | $19.0K | $58.0K | $281K | $144K | $86.0K | $676K | $398K | — |
| Free cash flow | -$13.7M | -$14.6M | -$16.8M | $3.17M | -$12.8M | -$19.9M | -$19.4M | -$16.7M | -$11.1M | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4.18M | $3.55M | $2.56M | $23.4M | $31.7M | $53.8M | $35.6M | $19.2M | $9.52M | $4.09M |
| Total assets | $16.7M | $16.0M | $14.7M | $36.1M | $38.1M | $58.8M | $41.0M | $34.0M | $9.94M | $4.14M |
| Total liabilities | $7.90M | $5.84M | $2.88M | $25.1M | $15.0M | $11.4M | $9.84M | $16.0M | $996K | $329K |
| Long-term debt | $3.22M | — | — | — | — | — | — | — | — | — |
| Shareholders' equity | $8.76M | $10.1M | $11.8M | $11.0M | $23.1M | $47.4M | $31.1M | $18.0M | $8.95M | $3.81M |
| Retained earnings | -$156M | -$174M | -$195M | -$215M | -$234M | -$255M | -$273M | -$288M | -$297M | -$302M |
| Shares (wtd avg diluted) | 14.9M | 2.10M | 4.92M | 10.0M | 1.81M | 2.71M | 3.45B | 3.65M | 3.65M | 3.65M |
Every figure is extracted from Pulmatrix, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.